TRUMP PULLS BACK BIDEN DRUG PRICING EO — The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling ...

NPR's Leila Fadel talks to Lina Khan, chair of the Federal Trade Commission, about drug companies holding patents on medications for much longer than they're supposed to. Most drug patents are meant ...

Antibody-drug conjugates (ADCs) are a rapidly emerging class of therapeutic agents that combine the target specificity of a monoclonal antibody (mAb) with the lethality of cytotoxic cellular poison.

New research suggests the war on drugs is hurting people with addiction, but lawmakers from both parties are demanding tougher crime policies to curb fentanyl overdoses. A growing number of lawmakers, ...

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial Both the magnitude and ...

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy. By Pam Belluck Pam ...